Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples